eletriptan hydrobromide
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
18 FDA-registered drug labelers
Advanced Rx of Tennessee, LLC
Aurobindo Pharma Limited
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Direct_Rx
F.I.S. FABBRICA ITALIANA SINTETICI SPA
Hetero Drugs Limited
Matrix Pharmacorp Private Limited
Mylan Pharmaceuticals Inc.
Pfizer Italia S.r.l.
Quality Care Products, LLC
ROERIG
Teva API India Private Ltd
Teva Pharmaceuticals USA, Inc.
Viatris Specialty LLC
Yung Shin Pharmaceutical Ind. Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Eletriptan hydrobromide
- •Relpax
- •Eletriptan HBR
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS177834-92-3
PubChem CID656631
DTXSIDDTXSID001016113
FormulaC22H27BrN2O2S
Mol. Weight463.4 g/mol
SMILESCN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br
Data Sources
6566312026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/eletriptan hydrobromide/cids/JSON
Archive: data/sources/pubchem_name/eletriptan hydrobromide.json
CAS 177834-92-32026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json